Ibritumomab Interactions
There are 354 drugs known to interact with ibritumomab, along with 3 disease interactions. Of the total drug interactions, 137 are major, 214 are moderate, and 3 are minor.
- View all 354 medications that may interact with ibritumomab
- View ibritumomab disease interactions (3)
Most frequently checked interactions
View interaction reports for ibritumomab and the medicines listed below.
- Activated Charcoal (charcoal)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Indium In-111 DTPA (indium pentetate in-111)
- Iodides (sodium iodide)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Ibritumomab disease interactions
There are 3 disease interactions with ibritumomab which include:
More about ibritumomab
- ibritumomab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.